glp 1 companies stock GLP-1 Antagonists Increase Plan Drug Spend - What's Next 2 Companies Poised to Capitalize
Description
The nausea, the fatigue, the gastrointestinal distress, these typically correlate with the concentration peak, not the average level
GLP-1R[1]
The therapeutic level needed for meaningful weight loss usually requires higher concentrations
Narcolepsy
Canagliflozin has been trialed in a phase IIb study in overweight and obese subjects without T2D
